Connect with us

Health

Genome editing to treat human retinal degeneration – EurekAlert

Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness….

Published

on

post featured image

IMAGE: Provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications.
view more 
Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, January 19, 2021–Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges are…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending